DRE Drug-Repurposing for Disease Category: Infections
Type to search for an organism*
Danio_rerio
Homo_sapiens
Mus_musculus
Rattus_norvegicus
Anolis_carolinensis
Bos_taurus
Caenorhabditis_elegans
Canis_lupus_familiaris
Drosophila_melanogaster
Equus_caballus
Felis_catus
Gallus_gallus
Macaca_mulatta
Monodelphis_domestica
Ornithorhynchus_anatinus
Pan_troglodytes
Saccharomyces_cerevisiae
Schizosaccharomyces_pombe_972h-
Sus_scrofa
Xenopus_tropicalis
Type to search for a disease*
Coronavirus/Sars-Cov/Covid-19
Ebola Virus Infection In Host
Helicobacter Pylori Infection
Hepatitis B Infection
HIV/AIDS
Leishmania Infection
Measles Virus Infection
Pathogenic Escherichia Coli Infection
Staphylococcus Aureus Infection
Tuberculosis
Vibrio Cholerae Infection
*Press backspace to delete current search
Pathway Category:
C2 (curated gene sets)
C4 (computational gene sets)
C5 (ontology gene sets)
C6 (oncogenic signature gene sets)
C7 (immunologic signature gene sets)
Note: The value of Tau score represents the extent of association of the drug with the pathway, such that a positive Tau (e.g. Tau = 100) of a pathway suggests that it is positively correlated with a drug and vice versa. Please note that both up/down regulated significant pathways (i.e., absolute Tau > 80) are shown for diseases, thus please refer to the Pathway_Description for further decripering of drug-pathway relationship.
Top Disease-Drug Associations
Query Table
Example
Loading...
Loading...
Loading...